Cargando…

PB2136: PLANNED-USE GLUCARPIDASE FOR OUTPATIENT HIGH DOSE METHOTREXATE (HD-MTX) ADMINISTRATION IN PATIENTS WITH CNS LYMPHOMA (CNSL) DURING THE COVID-19 PANDEMIC

Detalles Bibliográficos
Autores principales: Schaff, L., Lobbous, M., Carlow, D., DeAngelis, L., Nabors, L. B., Grommes, C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431396/
http://dx.doi.org/10.1097/01.HS9.0000851376.34315.4f
_version_ 1784780044189564928
author Schaff, L.
Lobbous, M.
Carlow, D.
DeAngelis, L.
Nabors, L. B.
Grommes, C.
author_facet Schaff, L.
Lobbous, M.
Carlow, D.
DeAngelis, L.
Nabors, L. B.
Grommes, C.
author_sort Schaff, L.
collection PubMed
description
format Online
Article
Text
id pubmed-9431396
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-94313962022-08-31 PB2136: PLANNED-USE GLUCARPIDASE FOR OUTPATIENT HIGH DOSE METHOTREXATE (HD-MTX) ADMINISTRATION IN PATIENTS WITH CNS LYMPHOMA (CNSL) DURING THE COVID-19 PANDEMIC Schaff, L. Lobbous, M. Carlow, D. DeAngelis, L. Nabors, L. B. Grommes, C. Hemasphere Publication Only Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9431396/ http://dx.doi.org/10.1097/01.HS9.0000851376.34315.4f Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Publication Only
Schaff, L.
Lobbous, M.
Carlow, D.
DeAngelis, L.
Nabors, L. B.
Grommes, C.
PB2136: PLANNED-USE GLUCARPIDASE FOR OUTPATIENT HIGH DOSE METHOTREXATE (HD-MTX) ADMINISTRATION IN PATIENTS WITH CNS LYMPHOMA (CNSL) DURING THE COVID-19 PANDEMIC
title PB2136: PLANNED-USE GLUCARPIDASE FOR OUTPATIENT HIGH DOSE METHOTREXATE (HD-MTX) ADMINISTRATION IN PATIENTS WITH CNS LYMPHOMA (CNSL) DURING THE COVID-19 PANDEMIC
title_full PB2136: PLANNED-USE GLUCARPIDASE FOR OUTPATIENT HIGH DOSE METHOTREXATE (HD-MTX) ADMINISTRATION IN PATIENTS WITH CNS LYMPHOMA (CNSL) DURING THE COVID-19 PANDEMIC
title_fullStr PB2136: PLANNED-USE GLUCARPIDASE FOR OUTPATIENT HIGH DOSE METHOTREXATE (HD-MTX) ADMINISTRATION IN PATIENTS WITH CNS LYMPHOMA (CNSL) DURING THE COVID-19 PANDEMIC
title_full_unstemmed PB2136: PLANNED-USE GLUCARPIDASE FOR OUTPATIENT HIGH DOSE METHOTREXATE (HD-MTX) ADMINISTRATION IN PATIENTS WITH CNS LYMPHOMA (CNSL) DURING THE COVID-19 PANDEMIC
title_short PB2136: PLANNED-USE GLUCARPIDASE FOR OUTPATIENT HIGH DOSE METHOTREXATE (HD-MTX) ADMINISTRATION IN PATIENTS WITH CNS LYMPHOMA (CNSL) DURING THE COVID-19 PANDEMIC
title_sort pb2136: planned-use glucarpidase for outpatient high dose methotrexate (hd-mtx) administration in patients with cns lymphoma (cnsl) during the covid-19 pandemic
topic Publication Only
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431396/
http://dx.doi.org/10.1097/01.HS9.0000851376.34315.4f
work_keys_str_mv AT schaffl pb2136planneduseglucarpidaseforoutpatienthighdosemethotrexatehdmtxadministrationinpatientswithcnslymphomacnslduringthecovid19pandemic
AT lobbousm pb2136planneduseglucarpidaseforoutpatienthighdosemethotrexatehdmtxadministrationinpatientswithcnslymphomacnslduringthecovid19pandemic
AT carlowd pb2136planneduseglucarpidaseforoutpatienthighdosemethotrexatehdmtxadministrationinpatientswithcnslymphomacnslduringthecovid19pandemic
AT deangelisl pb2136planneduseglucarpidaseforoutpatienthighdosemethotrexatehdmtxadministrationinpatientswithcnslymphomacnslduringthecovid19pandemic
AT naborslb pb2136planneduseglucarpidaseforoutpatienthighdosemethotrexatehdmtxadministrationinpatientswithcnslymphomacnslduringthecovid19pandemic
AT grommesc pb2136planneduseglucarpidaseforoutpatienthighdosemethotrexatehdmtxadministrationinpatientswithcnslymphomacnslduringthecovid19pandemic